Sponsor:
Washington University School of Medicine
Code:
NCT04629547
Conditions
Sleep
Alzheimer Disease
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Accepted
Interventions
Suvorexant 20 mg
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-24. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2025-12-17.